Target type: biologicalprocess
Any process that activates or increases the frequency, rate or extent of exo-alpha-sialidase activity. [GO_REF:0000059, GOC:BHF, GOC:rl, GOC:TermGenie, PMID:23544079]
Positive regulation of exo-alpha-sialidase activity involves a complex interplay of regulatory mechanisms that fine-tune the enzymatic activity of exo-alpha-sialidases, enzymes responsible for cleaving sialic acid residues from glycoconjugates. These regulatory processes are crucial for maintaining cellular homeostasis, modulating cell signaling pathways, and influencing various physiological functions.
One key regulatory mechanism is through the expression and activity of sialidase-specific activators. These activators, often proteins themselves, bind to exo-alpha-sialidases and enhance their catalytic efficiency. This enhancement can occur through various mechanisms, including:
* **Increased substrate affinity:** Activators can alter the conformation of the sialidase, increasing its binding affinity for the substrate, leading to a higher rate of enzyme-substrate interactions.
* **Stabilization of the active site:** Activators may bind to the active site of the sialidase, stabilizing its conformation and enhancing its catalytic activity.
* **Modulation of the microenvironment:** Activators can influence the local environment surrounding the sialidase, creating conditions more favorable for enzymatic activity.
In addition to specific activators, other factors can indirectly influence the positive regulation of exo-alpha-sialidase activity. These include:
* **Cellular signaling pathways:** Various intracellular signaling pathways, triggered by external stimuli, can modulate the expression and activity of exo-alpha-sialidases. For instance, specific growth factors or cytokines can activate signaling cascades leading to increased sialidase production or activation.
* **Post-translational modifications:** Modifications like phosphorylation, acetylation, or glycosylation can alter the activity of sialidases. These modifications can occur in response to cellular signals and affect the enzyme's stability, substrate binding, or catalytic activity.
* **Cellular localization:** The intracellular localization of sialidases plays a crucial role in their activity. Specific targeting signals within the sialidase protein can direct it to specific cellular compartments, allowing for the regulation of activity based on the location and availability of substrates.
Overall, positive regulation of exo-alpha-sialidase activity is a multifaceted process involving a variety of molecular mechanisms. Understanding these mechanisms is crucial for comprehending the physiological roles of sialidases in diverse cellular processes and their potential implication in various diseases.'
"
Protein | Definition | Taxonomy |
---|---|---|
Cytosolic beta-glucosidase | A cytosolic beta-glucosidase that is encoded in the genome of human. [PRO:DNx, UniProtKB:Q9H227] | Homo sapiens (human) |
Compound | Definition | Classes | Roles |
---|---|---|---|
1-deoxynojirimycin | 1-deoxy-nojirimycin: structure in first source duvoglustat : An optically active form of 2-(hydroxymethyl)piperidine-3,4,5-triol having 2R,3R,4R,5S-configuration. | 2-(hydroxymethyl)piperidine-3,4,5-triol; piperidine alkaloid | anti-HIV agent; anti-obesity agent; bacterial metabolite; EC 3.2.1.20 (alpha-glucosidase) inhibitor; hepatoprotective agent; hypoglycemic agent; plant metabolite |
2,5-dideoxy-2,5-imino-d-glucitol | 2,5-dideoxy-2,5-imino-D-glucitol: structure in first source | ||
validamine | validamine : An amino cyclitol consisting of 1D-chiro-inositol lacking the 6-hydroxy group and having those at positions 1 and 5 replaced by amino and hydroxymethyl groups respectively. validamine: RN given from CA Index Guide; RN not in Chemline 11/84; structure given in first source | amino cyclitol |